hotspot -WSS

hotspot

author：fashion 2025-09-29 21:14:36 - browse：63677

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Secretariat’s lessons for human medicine

hotspot

focus

WSS

New study raises questions about niacin and heart health

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Opioid cravings were reduced by anti

Teachers share how revamped forgiveness program helped with their student loans

Recent heat wave in the Mediterranean caused by climate change: Study

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

hotspot

hotspot

focus

Jerome Adams on the need for new antivirals for Covid

MD Anderson's Padmanee Sharma responds to research credit suit

Walensky prepares to leave CDC — and Congress — behind

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Alkermes shareholders re

Biden targets hefty hospital 'facility fees' that often surprise patients

Cancer drug shortages should be causing more outrage

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Jerome Adams on the need for new antivirals for Covid

FDA warns medical device makers about rise in fabricated data

Wikipedia

Hospitals are piloting generative AI tools as regulators play catch

Researchers tackle phage therapy hurdles for wider adoption

In 'major milestone,' FDA approves first cell therapy for solid tumors

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Biden declares emergency in flood

White House announces new plan to address the growing threat of xylazine in overdose crisis

hotspot

hotspot

focus

focus